These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

55 related items for PubMed ID: 2770704

  • 1. Type-A cholecystokinin binding sites in cow brain: characterization using (-)-[3H]L364718 membrane binding assays.
    Barrett RW, Steffey ME, Wolfram CA.
    Mol Pharmacol; 1989 Aug; 36(2):285-90. PubMed ID: 2770704
    [Abstract] [Full Text] [Related]

  • 2. Characterization of the binding of [3H]-(+/-)-L-364,718: a new potent, nonpeptide cholecystokinin antagonist radioligand selective for peripheral receptors.
    Chang RS, Lotti VJ, Chen TB, Kunkel KA.
    Mol Pharmacol; 1986 Sep; 30(3):212-7. PubMed ID: 3018478
    [Abstract] [Full Text] [Related]

  • 3. Characterization of the binding of [3H]L-365,260: a new potent and selective brain cholecystokinin (CCK-B) and gastrin receptor antagonist radioligand.
    Chang RS, Chen TB, Bock MG, Freidinger RM, Chen R, Rosegay A, Lotti VJ.
    Mol Pharmacol; 1989 Jun; 35(6):803-8. PubMed ID: 2733696
    [Abstract] [Full Text] [Related]

  • 4. Type-A cholecystokinin receptors in CHP212 neuroblastoma cells: evidence for association with G protein and activation of phosphoinositide hydrolysis.
    Barrett RW, Steffey ME, Wolfram CA.
    Mol Pharmacol; 1989 Apr; 35(4):394-400. PubMed ID: 2539554
    [Abstract] [Full Text] [Related]

  • 5. 3H-DOB (4-bromo-2,5-dimethoxyphenylisopropylamine) labels a guanyl nucleotide-sensitive state of cortical 5-HT2 receptors.
    Lyon RA, Davis KH, Titeler M.
    Mol Pharmacol; 1987 Feb; 31(2):194-9. PubMed ID: 3543649
    [Abstract] [Full Text] [Related]

  • 6. [3H]dihydroergotamine as a high-affinity, slowly dissociating radioligand for 5-HT1B binding sites in rat brain membranes: evidence for guanine nucleotide regulation of agonist affinity states.
    Hamblin MW, Ariani K, Adriaenssens PI, Ciaranello RD.
    J Pharmacol Exp Ther; 1987 Dec; 243(3):989-1001. PubMed ID: 2826763
    [Abstract] [Full Text] [Related]

  • 7. Nucleoside diphosphate kinase associated with rat pancreatic membranes regulates CCK receptor affinity.
    Blevins GT, van de Westerlo EM, Williams JA.
    Am J Physiol; 1994 Nov; 267(5 Pt 1):G866-74. PubMed ID: 7977749
    [Abstract] [Full Text] [Related]

  • 8. Comparison of [Dmt1]DALDA and DAMGO in binding and G protein activation at mu, delta, and kappa opioid receptors.
    Zhao GM, Qian X, Schiller PW, Szeto HH.
    J Pharmacol Exp Ther; 2003 Dec; 307(3):947-54. PubMed ID: 14534366
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Quantitative film autoradiography of opiate agonist and antagonist binding in rat brain.
    Geary WA, Wooten GF.
    J Pharmacol Exp Ther; 1983 Apr; 225(1):234-40. PubMed ID: 6300375
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Determination and characterization of a cannabinoid receptor in rat brain.
    Devane WA, Dysarz FA, Johnson MR, Melvin LS, Howlett AC.
    Mol Pharmacol; 1988 Nov; 34(5):605-13. PubMed ID: 2848184
    [Abstract] [Full Text] [Related]

  • 18. Characterization of [3H]-forskolin binding sites in young and adult rat brain cortex: identification of suramin as a competitive inhibitor of [3H]-forskolin binding.
    Stöhr J, Novotny J, Svoboda P.
    Can J Physiol Pharmacol; 2005 Jul; 83(7):573-81. PubMed ID: 16091783
    [Abstract] [Full Text] [Related]

  • 19. Characterization of specific binding sites for [3H](d)-N-allylnormetazocine in rat brain membranes.
    Itzhak Y, Hiller JM, Simon EJ.
    Mol Pharmacol; 1985 Jan; 27(1):46-52. PubMed ID: 3965930
    [Abstract] [Full Text] [Related]

  • 20. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. II. Characterization and regulation of antagonist binding to putative muscarinic subtypes.
    Watson M, Roeske WR, Yamamura HI.
    J Pharmacol Exp Ther; 1986 May; 237(2):419-27. PubMed ID: 3754581
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.